Search Results 1171-1180 of 17460 for Teratogenic

  1. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or ...

  2. Immune thrombocytopenia (ITP) - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  3. Oncology (Medical) - Clinical trials

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  5. Clinical trials - Oncology (Medical)

    Jacksonville, Fla. The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as ...

  6. Neurosurgery - Clinical trials

    The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid hemorrhage (aSAH)- ...

  7. Assessing Patient Outcomes Following Treatment with Ceftolozane/Tazobactam (C/T) - Mayo Clinic

    The purpose of this study is to evaluate the real-world utilization of ceftolozane/tazobactam (C/T) and to assess patient outcomes. Participation eligibility.

  8. A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors - Mayo Clinic

    LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene). Participation could last ...

  9. Clinical trials - Oncology (Medical)

    Scottsdale/Phoenix, Ariz. The purpose of this study is to identify subtype-specific signatures for breast cancer using genomic positioning of plasma DNA ...

  10. A Study to Evaluate the Effectiveness and Safety of AKCEA-TTR-LRx in Patients with ATTR CM - Mayo Clinic

    To evaluate the effectiveness of AKCEA-TTR-LRx compared to placebo for 120 weeks in patients with ATTR-CM receiving available standard of care (SoC). For more ...